You are required to be logged in to access the full website
Click here if you have forgotten your username or password
21 September 2026 - Ocular Therapeutix Inc (NASDAQ:OCUL), an integrated biopharmaceutical company focused on retinal disease, said on Friday that it has granted inducement equity awards to nine newly hired non-executive employees.The awards were made...
21 September 2026 - French biopharmaceutical company Ipsen (Euronext Paris:IPN) (ADR:IPSEY) announced on Friday the appointment of Mariette Finet as a director to its board of directors, effective immediately.Finet succeeds Michele Ollier, who resign...
21 September 2026 - Oncology company Coiled Therapeutics plc (AIM: COIL) (OTCQB: COTXF) declared on Monday that it has completed enrollment across two cohorts evaluating its new lipid-based softgel formulation of AO-252, enrolling three patients each...
18 September 2026 - Clinical-stage biotechnology company MaaT Pharma (Euronext Paris:MAAT) confirmed on Friday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has maintained its negative opinion o...
18 September 2026 - Global healthcare company Abbott (NYSE:ABT) announced on Thursday that its board of directors has declared a quarterly dividend of USD0.63 per share of common stock.This marks the 411th consecutive quarterly dividend to be paid by...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe